1. Opioid agonist-antagonist/opioid antagonist combinations
1.1. DRUGS
1.1.1. Suboxone
1.1.1.1. buprenorphine
1.1.1.2. naloxone
2. Opioid antagonists
2.1. DETAILS
2.2. DRUGS
2.2.1. Naloxone (Narcan, Ezvio)
2.2.1.1. Nasal = Narcan or injectable generic with atomizer)
2.2.1.2. IM/SC = Evzio auto injector
2.2.1.3. IV: generic naloxone
2.2.2. Naltrexone (ReVia)
2.2.3. Nalmefene (Revex)
3. Opioid agonists-antagonists
3.1. DETAILS
3.2. DRUGS
3.2.1. Bupenorphine
3.2.1.1. schedule III
3.2.1.2. IV, IM, SL, transdermal
3.2.2. Butorphanol
3.2.2.1. schedule IV
3.2.2.2. IV, IM, intranasal
3.2.3. Nalbuphine
3.2.3.1. not scheduled
3.2.3.2. IV, IM
3.2.4. Pentazocine
3.2.4.1. schedule IV
3.2.4.2. PO, IV, IM
3.3. ADR
4. Opioid agonist/opioid antagonist combinations
4.1. DETAILS
4.2. DRUGS
4.2.1. Targiniq ER (II)
4.2.1.1. Oxycodone
4.2.1.2. naloxone
4.2.2. Embeda (II)
4.2.2.1. morphine
4.2.2.2. naltrexone
5. Opioid agonists
5.1. DRUGS
5.1.1. Morphine (II)
5.1.2. Fenatyl (II)
5.1.3. Hydromorphone (II)
5.1.4. Meperidine (II)
5.1.5. Methadone (II)
5.1.6. Hydrocodone (II)
5.1.7. Oxycodone (II)
5.1.8. Codeine (II, III, IV)